Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Calumet Specialty Products Partners, L.P.CLMT · Entity 91042 | Director | November 07, 2023 | November 09, 2023 |
| Calumet, Inc. /DECLMT · Entity 3988 | Director | July 09, 2026 | July 13, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Calumet Specialty Products Partners, L.P.
Report date November 07, 2023 · Filed November 09, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Phantom UnitsSEC Table II · derivative / convertible security | Direct | 7,490 |
Reported balance
After 2023-11-07 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2023-11-07 · Grant · Acquired 7,490 · Balance 7,490 F1: Each Phantom Unit is the economic equivalent of a Calumet Specialty Products Partners, L.P. Common Unit. F2: Phantom Units vest on November 7, 2026. Phantom Units will be settled upon vesting. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Phantom Unit is the economic equivalent of a Calumet Specialty Products Partners, L.P. Common Unit.
F2: Phantom Units vest on November 7, 2026. Phantom Units will be settled upon vesting.
Calumet, Inc. /DE
Report date July 09, 2026 · Filed July 13, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.01 per shareSEC Table I · non-derivative | Direct | 81,958 |
Ending reported balance
After 2026-07-09 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-07-09 · Exercise / conversion · Acquired 7,067 · Balance 84,785 Row 2 · 2026-07-09 · Tax withholding · Disposed 2,827 · Balance 81,958 F1: The reporting person elected to surrender 2,827 shares of Calumet, Inc. common stock, par value $0.01 per share, to satisfy tax withholding liabilities upon delivery of common stock in accordance with Rule 16b-3. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-07-09 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-07-09 · Exercise / conversion · Disposed 7,067 · Balance 0 F2: Each Restricted Stock Unit is the economic equivalent of one share of Calumet, Inc. common stock, par value $0.01 per share. F3: 100% of the Restricted Stock Units vested on June 2, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: The reporting person elected to surrender 2,827 shares of Calumet, Inc. common stock, par value $0.01 per share, to satisfy tax withholding liabilities upon delivery of common stock in accordance with Rule 16b-3.
F2: Each Restricted Stock Unit is the economic equivalent of one share of Calumet, Inc. common stock, par value $0.01 per share.
F3: 100% of the Restricted Stock Units vested on June 2, 2026.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 09, 2026 Filed Jul 13, 2026 20:06 UTC | Calumet, Inc. /DE CLMT · Entity 3988 | Exercise / conversionRestricted Stock Unit · Derivative | 7,067 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-048015 · wk-form4_1783973189.xml · derivative · entry 3 Sajkowski Daniel J · CIK 0001619678 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, par value $0.01 per share · 7,067 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit is the economic equivalent of one share of Calumet, Inc. common stock, par value $0.01 per share. F3 · derivative.exercise_date: 100% of the Restricted Stock Units vested on June 2, 2026. F3 · derivative.expiration_date: 100% of the Restricted Stock Units vested on June 2, 2026. Read SEC document |
| July 09, 2026 Filed Jul 13, 2026 20:06 UTC | Calumet, Inc. /DE CLMT · Entity 3988 | Tax withholdingCommon Stock, par value $0.01 per share | 2,827 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-048015 · wk-form4_1783973189.xml · nonDerivative · entry 2 Sajkowski Daniel J · CIK 0001619678 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,958 F1 · shares: The reporting person elected to surrender 2,827 shares of Calumet, Inc. common stock, par value $0.01 per share, to satisfy tax withholding liabilities upon delivery of common stock in accordance with Rule 16b-3. Read SEC document |
| July 09, 2026 Filed Jul 13, 2026 20:06 UTC | Calumet, Inc. /DE CLMT · Entity 3988 | Exercise / conversionCommon Stock, par value $0.01 per share | 7,067 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-048015 · wk-form4_1783973189.xml · nonDerivative · entry 1 Sajkowski Daniel J · CIK 0001619678 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,785 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 01, 2026 Filed Jul 2, 2026 21:27 UTC | Calumet, Inc. /DE CLMT · Entity 3988 | SaleCommon Stock, par value $0.01 per share | 4,240 | $36.16 | $153,318.40 |
DisclosureSEC source: 0001628280-26-047050 · wk-form4_1783027655.xml · nonDerivative · entry 1 Sajkowski Daniel J · CIK 0001619678 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,718 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2025. The closing price of one share of Calumet, Inc. common stock, as reported on the Nasdaq Global Select Market, on the date the Rule 10b5-1 trading plan was adopted by the reporting person was $19.08 per share. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.72 per share to $36.33 per share. The reporting person undertakes to provide to Calumet, Inc., any security holder of Calumet, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Read SEC document |
| June 02, 2026 Filed Jun 4, 2026 20:22 UTC | Calumet, Inc. /DE CLMT · Entity 3988 | GrantRestricted Stock Unit · Derivative | 3,461 | $0.00 | $0.00 |
DisclosureSEC source: 0001619678-26-000006 · form4-06042026_080639.xml · derivative · entry 1 Sajkowski Daniel J · CIK 0001619678 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,461 Underlying: Common Stock, par value $0.01 per share · 3,461 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit is the economic equivalent of one share of Calumet, Inc. common stock, par value $0.01 per share. F2 · derivative.exercise_date: Restricted Stock Units vest upon the earlier of June 2, 2027 or the date on which Calumet, Inc. holds its Annual Meeting in 2027. Restricted Stock Units will be settled upon vesting. F2 · derivative.expiration_date: Restricted Stock Units vest upon the earlier of June 2, 2027 or the date on which Calumet, Inc. holds its Annual Meeting in 2027. Restricted Stock Units will be settled upon vesting. Read SEC document |
| April 01, 2026 Filed Apr 2, 2026 20:19 UTC | Calumet, Inc. /DE CLMT · Entity 3988 | SaleCommon Stock, par value $0.01 per share | 3,310 | $34.46 | $114,062.60 |
DisclosureSEC source: 0001619678-26-000005 · form4-04022026_080423.xml · nonDerivative · entry 1 Sajkowski Daniel J · CIK 0001619678 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,958 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2025. The closing price of one share of Calumet, Inc. common stock, as reported on the Nasdaq Global Select Market, on the date the Rule 10b5-1 trading plan was adopted by the reporting person was $19.08 per share. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.75 per share to $35.84 per share. The reporting person undertakes to provide to Calumet, Inc., any security holder of Calumet, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Read SEC document |
| December 04, 2025 Filed Dec 5, 2025 20:56 UTC | Calumet, Inc. /DE CLMT · Entity 3988 | Exercise / conversionRestricted Stock Unit · Derivative | 5,053 | $0.00 | $0.00 |
DisclosureSEC source: 0001619678-25-000003 · form4-12052025_081230.xml · derivative · entry 3 Sajkowski Daniel J · CIK 0001619678 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, par value $0.01 per share · 5,053 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit is the economic equivalent of one share of Calumet, Inc. common stock, par value $0.01 per share. F3 · derivative.exercise_date: Each Restricted Stock Unit becomes payable either in the form of one share of Calumet, Inc. common stock, par value $0.01 per share, or the cash value thereof. Restricted Stock Units are 100% vested. F3 · derivative.expiration_date: Each Restricted Stock Unit becomes payable either in the form of one share of Calumet, Inc. common stock, par value $0.01 per share, or the cash value thereof. Restricted Stock Units are 100% vested. Read SEC document |
| December 04, 2025 Filed Dec 5, 2025 20:56 UTC | Calumet, Inc. /DE CLMT · Entity 3988 | SaleCommon Stock, par value $0.01 per share | 2,022 | $0.00 | $0.00 |
DisclosureSEC source: 0001619678-25-000003 · form4-12052025_081230.xml · nonDerivative · entry 2 Sajkowski Daniel J · CIK 0001619678 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 167,268 F1 · shares: The reporting person elected to receive 40% of Restricted Stock Units vested and reported here within to be settled in the cash equivalent of a Calumet, Inc. common share. Read SEC document |
| December 04, 2025 Filed Dec 5, 2025 20:56 UTC | Calumet, Inc. /DE CLMT · Entity 3988 | Exercise / conversionCommon Stock, par value $0.01 per share | 5,053 | $0.00 | $0.00 |
DisclosureSEC source: 0001619678-25-000003 · form4-12052025_081230.xml · nonDerivative · entry 1 Sajkowski Daniel J · CIK 0001619678 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 169,290 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 04, 2025 Filed Feb 27, 2026 01:53 UTC Amendment | Calumet, Inc. /DE CLMT · Entity 3988 | Exercise / conversionRestricted Stock Unit · Derivative | 5,053 | $0.00 | $0.00 |
DisclosureSEC source: 0001619678-26-000004 · form4a-02272026_010255.xml · derivative · entry 3 Sajkowski Daniel J · CIK 0001619678 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, par value $0.01 per share · 5,053 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit is the economic equivalent of one share of Calumet, Inc. common stock, par value $0.01 per share. F3 · derivative.exercise_date: Each Restricted Stock Unit becomes payable either in the form of one share of Calumet, Inc. common stock, par value $0.01 per share, or the cash value thereof. Restricted Stock Units are 100% vested. F3 · derivative.expiration_date: Each Restricted Stock Unit becomes payable either in the form of one share of Calumet, Inc. common stock, par value $0.01 per share, or the cash value thereof. Restricted Stock Units are 100% vested. Read SEC document |
| December 04, 2025 Filed Feb 27, 2026 01:53 UTC Amendment | Calumet, Inc. /DE CLMT · Entity 3988 | SaleCommon Stock, par value $0.01 per share | 2,022 | $0.00 | $0.00 |
DisclosureSEC source: 0001619678-26-000004 · form4a-02272026_010255.xml · nonDerivative · entry 2 Sajkowski Daniel J · CIK 0001619678 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85,268 F1 · shares: The reporting person elected to receive 40% of Restricted Stock Units vested and reported here within to be settled in the cash equivalent of a Calumet, Inc. common share. Read SEC document |
| December 04, 2025 Filed Feb 27, 2026 01:53 UTC Amendment | Calumet, Inc. /DE CLMT · Entity 3988 | Exercise / conversionCommon Stock, par value $0.01 per share | 5,053 | $0.00 | $0.00 |
DisclosureSEC source: 0001619678-26-000004 · form4a-02272026_010255.xml · nonDerivative · entry 1 Sajkowski Daniel J · CIK 0001619678 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,290 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 01, 2025 Filed Feb 27, 2026 01:51 UTC | Calumet, Inc. /DE CLMT · Entity 3988 | SaleCommon Stock, par value $0.01 per share | 2,000 | $15.77 | $31,540.00 |
DisclosureSEC source: 0001619678-26-000002 · form4-02272026_010253.xml · nonDerivative · entry 5 Sajkowski Daniel J · CIK 0001619678 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 82,237 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2024. The closing price of one common unit of Calumet Specialty Products Partners, L.P., (the "Partnership") as reported on the Nasdaq Global Select Market, on the date the Rule 10b5-1 trading plan was adopted by the reporting person was $14.25 per unit. On July 10, 2024, Calumet, Inc. became the successor issuer to, and parent holding company of, the Partnership pursuant to a conversion transaction in which all of the Partnership's outstanding common units representing limited partner interests were automatically exchanged into an equal number of shares of Calumet, Inc. common stock. F6 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.53 per share to $16.02 per share. The reporting person undertakes to provide to Calumet, Inc., any security holder of Calumet, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (6) to this Form 4. Read SEC document |
| June 24, 2025 Filed Oct 3, 2025 20:00 UTC | Calumet, Inc. /DE CLMT · Entity 3988 | Exercise / conversionRestricted Stock Unit · Derivative | 3,796 | $0.00 | $0.00 |
DisclosureSEC source: 0001619678-25-000002 · form4-10032025_081017.xml · derivative · entry 3 Sajkowski Daniel J · CIK 0001619678 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, par value $0.01 per share · 3,796 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit is the economic equivalent of one share of Calumet, Inc. common stock, par value $0.01 per share. F3 · derivative.exercise_date: Each Restricted Stock Unit becomes payable either in the form of one share of Calumet, Inc. common stock, par value $0.01 per share, or the cash value thereof. Restricted Stock Units are 100% vested. F3 · derivative.expiration_date: Each Restricted Stock Unit becomes payable either in the form of one share of Calumet, Inc. common stock, par value $0.01 per share, or the cash value thereof. Restricted Stock Units are 100% vested. Read SEC document |
| June 24, 2025 Filed Oct 3, 2025 20:00 UTC | Calumet, Inc. /DE CLMT · Entity 3988 | SaleCommon Stock, par value $0.01 per share | 1,518 | $0.00 | $0.00 |
DisclosureSEC source: 0001619678-25-000002 · form4-10032025_081017.xml · nonDerivative · entry 2 Sajkowski Daniel J · CIK 0001619678 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 164,237 F1 · shares: The reporting person elected to receive 40% of Restricted Stock Units vested and reported here within to be settled in the cash equivalent of a Calumet, Inc. common share. Read SEC document |
| June 24, 2025 Filed Oct 3, 2025 20:00 UTC | Calumet, Inc. /DE CLMT · Entity 3988 | Exercise / conversionCommon Stock, par value $0.01 per share | 3,796 | $0.00 | $0.00 |
DisclosureSEC source: 0001619678-25-000002 · form4-10032025_081017.xml · nonDerivative · entry 1 Sajkowski Daniel J · CIK 0001619678 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 165,755 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 24, 2025 Filed Feb 27, 2026 01:53 UTC Amendment | Calumet, Inc. /DE CLMT · Entity 3988 | Exercise / conversionRestricted Stock Unit · Derivative | 3,796 | $0.00 | $0.00 |
DisclosureSEC source: 0001619678-26-000003 · form4a-02272026_010203.xml · derivative · entry 3 Sajkowski Daniel J · CIK 0001619678 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, par value $0.01 per share · 3,796 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit is the economic equivalent of one share of Calumet, Inc. common stock, par value $0.01 per share. F3 · derivative.exercise_date: Each Restricted Stock Unit becomes payable either in the form of one share of Calumet, Inc. common stock, par value $0.01 per share, or the cash value thereof. Restricted Stock Units are 100% vested. F3 · derivative.expiration_date: Each Restricted Stock Unit becomes payable either in the form of one share of Calumet, Inc. common stock, par value $0.01 per share, or the cash value thereof. Restricted Stock Units are 100% vested. Read SEC document |
| June 24, 2025 Filed Feb 27, 2026 01:53 UTC Amendment | Calumet, Inc. /DE CLMT · Entity 3988 | SaleCommon Stock, par value $0.01 per share | 1,518 | $0.00 | $0.00 |
DisclosureSEC source: 0001619678-26-000003 · form4a-02272026_010203.xml · nonDerivative · entry 2 Sajkowski Daniel J · CIK 0001619678 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,237 F1 · shares: The reporting person elected to receive 40% of Restricted Stock Units vested and reported here within to be settled in the cash equivalent of a Calumet, Inc. common share. Read SEC document |
| June 24, 2025 Filed Feb 27, 2026 01:53 UTC Amendment | Calumet, Inc. /DE CLMT · Entity 3988 | Exercise / conversionCommon Stock, par value $0.01 per share | 3,796 | $0.00 | $0.00 |
DisclosureSEC source: 0001619678-26-000003 · form4a-02272026_010203.xml · nonDerivative · entry 1 Sajkowski Daniel J · CIK 0001619678 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85,755 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 11, 2025 Filed Jun 13, 2025 20:06 UTC | Calumet, Inc. /DE CLMT · Entity 3988 | GrantRestricted Stock Unit · Derivative | 7,067 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-017172 · form4-06132025_080653.xml · derivative · entry 1 Sajkowski Daniel J · CIK 0001619678 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,067 Underlying: Common Stock, par value $0.01 per share · 7,067 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit is the economic equivalent of one share of Calumet, Inc. common stock, par value $0.01 per share. F2 · derivative.exercise_date: Restricted Stock Units vest upon the earlier of June 11, 2026 or the date on which Calumet, Inc. holds its Annual Meeting in 2026. Restricted Stock Units will be settled upon vesting. F2 · derivative.expiration_date: Restricted Stock Units vest upon the earlier of June 11, 2026 or the date on which Calumet, Inc. holds its Annual Meeting in 2026. Restricted Stock Units will be settled upon vesting. Read SEC document |
| June 09, 2025 Filed Jun 12, 2025 00:00 UTC | Calumet, Inc. /DE CLMT · Entity 3988 | GrantRestricted Stock Unit · Derivative | 3,796 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-016769 · form4-06122025_120608.xml · derivative · entry 1 Sajkowski Daniel J · CIK 0001619678 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,796 Underlying: Common Stock, par value $0.01 per share · 3,796 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit is the economic equivalent of one share of Calumet, Inc. common stock, par value $0.01 per share. F2 · derivative.exercise_date: Restricted Stock Units are 100% vested. Restricted Stock Units will be settled upon vesting. F2 · derivative.expiration_date: Restricted Stock Units are 100% vested. Restricted Stock Units will be settled upon vesting. Read SEC document |
| June 02, 2025 Filed Feb 27, 2026 01:51 UTC | Calumet, Inc. /DE CLMT · Entity 3988 | SaleCommon Stock, par value $0.01 per share | 20,000 | $13.40 | $268,000.00 |
DisclosureSEC source: 0001619678-26-000002 · form4-02272026_010253.xml · nonDerivative · entry 4 Sajkowski Daniel J · CIK 0001619678 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 81,959 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2024. The closing price of one common unit of Calumet Specialty Products Partners, L.P., (the "Partnership") as reported on the Nasdaq Global Select Market, on the date the Rule 10b5-1 trading plan was adopted by the reporting person was $14.25 per unit. On July 10, 2024, Calumet, Inc. became the successor issuer to, and parent holding company of, the Partnership pursuant to a conversion transaction in which all of the Partnership's outstanding common units representing limited partner interests were automatically exchanged into an equal number of shares of Calumet, Inc. common stock. F5 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.07 per share to $13.86 per share. The reporting person undertakes to provide to Calumet, Inc., any security holder of Calumet, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (5) to this Form 4. Read SEC document |
| May 01, 2025 Filed Feb 27, 2026 01:51 UTC | Calumet, Inc. /DE CLMT · Entity 3988 | SaleCommon Stock, par value $0.01 per share | 20,000 | $10.66 | $213,200.00 |
DisclosureSEC source: 0001619678-26-000002 · form4-02272026_010253.xml · nonDerivative · entry 3 Sajkowski Daniel J · CIK 0001619678 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 101,959 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2024. The closing price of one common unit of Calumet Specialty Products Partners, L.P., (the "Partnership") as reported on the Nasdaq Global Select Market, on the date the Rule 10b5-1 trading plan was adopted by the reporting person was $14.25 per unit. On July 10, 2024, Calumet, Inc. became the successor issuer to, and parent holding company of, the Partnership pursuant to a conversion transaction in which all of the Partnership's outstanding common units representing limited partner interests were automatically exchanged into an equal number of shares of Calumet, Inc. common stock. F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.40 per share to $10.90 per share. The reporting person undertakes to provide to Calumet, Inc., any security holder of Calumet, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (4) to this Form 4. Read SEC document |
| April 01, 2025 Filed Feb 27, 2026 01:51 UTC | Calumet, Inc. /DE CLMT · Entity 3988 | SaleCommon Stock, par value $0.01 per share | 20,000 | $12.55 | $251,000.00 |
DisclosureSEC source: 0001619678-26-000002 · form4-02272026_010253.xml · nonDerivative · entry 2 Sajkowski Daniel J · CIK 0001619678 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 121,959 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2024. The closing price of one common unit of Calumet Specialty Products Partners, L.P., (the "Partnership") as reported on the Nasdaq Global Select Market, on the date the Rule 10b5-1 trading plan was adopted by the reporting person was $14.25 per unit. On July 10, 2024, Calumet, Inc. became the successor issuer to, and parent holding company of, the Partnership pursuant to a conversion transaction in which all of the Partnership's outstanding common units representing limited partner interests were automatically exchanged into an equal number of shares of Calumet, Inc. common stock. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.06 per share to $12.91 per share. The reporting person undertakes to provide to Calumet, Inc., any security holder of Calumet, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4. Read SEC document |
| March 03, 2025 Filed Feb 27, 2026 01:51 UTC | Calumet, Inc. /DE CLMT · Entity 3988 | SaleCommon Stock, par value $0.01 per share | 20,000 | $13.73 | $274,600.00 |
DisclosureSEC source: 0001619678-26-000002 · form4-02272026_010253.xml · nonDerivative · entry 1 Sajkowski Daniel J · CIK 0001619678 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 141,959 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2024. The closing price of one common unit of Calumet Specialty Products Partners, L.P., (the "Partnership") as reported on the Nasdaq Global Select Market, on the date the Rule 10b5-1 trading plan was adopted by the reporting person was $14.25 per unit. On July 10, 2024, Calumet, Inc. became the successor issuer to, and parent holding company of, the Partnership pursuant to a conversion transaction in which all of the Partnership's outstanding common units representing limited partner interests were automatically exchanged into an equal number of shares of Calumet, Inc. common stock. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.35 per share to $14.06 per share. The reporting person undertakes to provide to Calumet, Inc., any security holder of Calumet, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Read SEC document |
| December 04, 2024 Filed Dec 5, 2024 21:32 UTC | Calumet, Inc. /DE CLMT · Entity 3988 | Exercise / conversionRestricted Stock Unit · Derivative | 8,921 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-028405 · form4-12052024_091215.xml · derivative · entry 3 Sajkowski Daniel J · CIK 0001619678 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, par value $0.01 per share · 8,921 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit is the economic equivalent of one share of Calumet, Inc. common stock, par value $0.01 per share. F3 · derivative.exercise_date: 100% of the Restricted Stock Units vested on November 3, 2024. F3 · derivative.expiration_date: 100% of the Restricted Stock Units vested on November 3, 2024. Read SEC document |
| December 04, 2024 Filed Dec 5, 2024 21:32 UTC | Calumet, Inc. /DE CLMT · Entity 3988 | SaleCommon Stock, par value $0.01 per share | 3,569 | $21.12 | $75,377.28 |
DisclosureSEC source: 0001415889-24-028405 · form4-12052024_091215.xml · nonDerivative · entry 2 Sajkowski Daniel J · CIK 0001619678 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 161,959 F1 · shares: The reporting person elected to receive 40% of all Restricted Stock Units vesting in the year ending December 31, 2024 to be settled in the cash equivalent of a Calumet, Inc. common share. Read SEC document |
| December 04, 2024 Filed Dec 5, 2024 21:32 UTC | Calumet, Inc. /DE CLMT · Entity 3988 | Exercise / conversionCommon Stock, par value $0.01 per share | 8,921 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-028405 · form4-12052024_091215.xml · nonDerivative · entry 1 Sajkowski Daniel J · CIK 0001619678 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 165,528 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 07, 2024 Filed Nov 12, 2024 14:40 UTC | Calumet, Inc. /DE CLMT · Entity 3988 | GrantRestricted Stock Unit · Derivative | 4,935 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-026506 · form4-11122024_021154.xml · derivative · entry 1 Sajkowski Daniel J · CIK 0001619678 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,935 Underlying: Common Stock, par value $0.01 per share · 4,935 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit is the economic equivalent of one share of Calumet, Inc. common stock, par value $0.01 per share. F2 · derivative.exercise_date: Restricted Stock Units vest on November 7, 2027. Restricted Stock Units will be settled upon vesting. F2 · derivative.expiration_date: Restricted Stock Units vest on November 7, 2027. Restricted Stock Units will be settled upon vesting. Read SEC document |
| November 07, 2023 Filed Nov 9, 2023 17:24 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | GrantPhantom Units · Derivative | 7,490 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-014962 · form4-11092023_101106.xml · derivative · entry 1 Sajkowski Daniel J · CIK 0001619678 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,490 Underlying: Common Units · 7,490 shares Expires not disclosed F1 · derivative.exercise_price: Each Phantom Unit is the economic equivalent of a Calumet Specialty Products Partners, L.P. Common Unit. F2 · derivative.exercise_date: Phantom Units vest on November 7, 2026. Phantom Units will be settled upon vesting. F2 · derivative.expiration_date: Phantom Units vest on November 7, 2026. Phantom Units will be settled upon vesting. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 18:54 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | SaleCommon Units | 11,142 | $19.52 | $217,491.84 |
DisclosureSEC source: 0001340122-23-000019 · wf-form4_167788767158703.xml · nonDerivative · entry 1 Sajkowski Daniel J · CIK 0001619678 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,607 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 17, 2022. Read SEC document |
| February 03, 2023 Filed Feb 7, 2023 15:25 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | Exercise / conversionPhantom Units · Derivative | 27,855 | $0.00 | $0.00 |
DisclosureSEC source: 0001340122-23-000003 · wf-form4_167580149175533.xml · derivative · entry 2 Sajkowski Daniel J · CIK 0001619678 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Units · 27,855 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Phantom Unit is the economic equivalent of a Calumet Specialty Products Partners, L.P. Common Unit. F2 · derivative.exercise_date: 100% of the Phantom Units vest on December 31, 2022. F2 · derivative.expiration_date: 100% of the Phantom Units vest on December 31, 2022. Read SEC document |
| February 03, 2023 Filed Feb 7, 2023 15:25 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | Exercise / conversionCommon Units | 27,855 | $0.00 | $0.00 |
DisclosureSEC source: 0001340122-23-000003 · wf-form4_167580149175533.xml · nonDerivative · entry 1 Sajkowski Daniel J · CIK 0001619678 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 167,749 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 01, 2022 Filed Nov 3, 2022 16:28 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | GrantPhantom Units · Derivative | 5,053 | $0.00 | $0.00 |
DisclosureSEC source: 0001340122-22-000103 · wf-form4_166750728371309.xml · derivative · entry 1 Sajkowski Daniel J · CIK 0001619678 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,053 Underlying: Common Units · 5,053 shares Expires not disclosed F1 · derivative.exercise_price: Each Phantom Unit is the economic equivalent of a Calumet Specialty Products Partners, L.P. Common Unit. F2 · derivative.exercise_date: Phantom Units vest on November 1, 2025. Phantom Units will be settled upon vesting. F2 · derivative.expiration_date: Phantom Units vest on November 1, 2025. Phantom Units will be settled upon vesting. Read SEC document |
| August 15, 2022 Filed Aug 22, 2022 11:46 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | GiftCommon Units | 2,428 | $0.00 | $0.00 |
DisclosureSEC source: 0001340122-22-000101 · wf-form4_166118315419921.xml · nonDerivative · entry 1 Sajkowski Daniel J · CIK 0001619678 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,894 F1 · kind: The transaction is a donation of CLMT units to a charitable organization. F1 · shares: The transaction is a donation of CLMT units to a charitable organization. F1 · acquired: The transaction is a donation of CLMT units to a charitable organization. Read SEC document |
| March 04, 2022 Filed Mar 8, 2022 09:49 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | Exercise / conversionPhantom Units · Derivative | 7,103 | $0.00 | $0.00 |
DisclosureSEC source: 0001340122-22-000046 · wf-form4_164675098010862.xml · derivative · entry 2 Sajkowski Daniel J · CIK 0001619678 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Unit · 7,103 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Phantom Unit is the economic equivalent of a Calumet Specialty Products Partners, L.P. Common Unit. F2 · derivative.exercise_date: 25% of the Phantom Units vested immediately and the remaining vest ratably over three years on December 31 of each year beginning on December 31, 2019. F2 · derivative.expiration_date: 25% of the Phantom Units vested immediately and the remaining vest ratably over three years on December 31 of each year beginning on December 31, 2019. Read SEC document |
| March 04, 2022 Filed Mar 8, 2022 09:49 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | Exercise / conversionCommon Units | 7,103 | $0.00 | $0.00 |
DisclosureSEC source: 0001340122-22-000046 · wf-form4_164675098010862.xml · nonDerivative · entry 1 Sajkowski Daniel J · CIK 0001619678 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,322 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 03, 2021 Filed Nov 5, 2021 20:42 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | GrantPhantom Units · Derivative | 8,921 | $0.00 | $0.00 |
DisclosureSEC source: 0001340122-21-000101 · wf-form4_163615932700925.xml · derivative · entry 1 Sajkowski Daniel J · CIK 0001619678 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,921 Underlying: Common Units · 8,921 shares Expires not disclosed F1 · derivative.exercise_price: Each Phantom Unit is the economic equivalent of a Calumet Specialty Products Partners, L.P. Common Unit. F2 · derivative.exercise_date: Phantom Units vest on December 31, 2023. Phantom Units will be settled upon vesting. F2 · derivative.expiration_date: Phantom Units vest on December 31, 2023. Phantom Units will be settled upon vesting. Read SEC document |
| March 03, 2021 Filed Mar 4, 2021 18:00 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | Exercise / conversionPhantom Units · Derivative | 7,102 | $0.00 | $0.00 |
DisclosureSEC source: 0001340122-21-000042 · wf-form4_161489881371538.xml · derivative · entry 6 Sajkowski Daniel J · CIK 0001619678 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,102 Underlying: Common Units · 7,102 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Phantom Unit is the economic equivalent of a Calumet Specialty Products Partners, L.P. Common Unit. F4 · derivative.exercise_date: 25% of the Phantom Units vested immediately and the remaining vest ratably over three years on December 31 of each year beginning on December 31, 2019. F4 · derivative.expiration_date: 25% of the Phantom Units vested immediately and the remaining vest ratably over three years on December 31 of each year beginning on December 31, 2019. Read SEC document |
| March 03, 2021 Filed Mar 4, 2021 18:00 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | Exercise / conversionPhantom Units · Derivative | 41,201 | $0.00 | $0.00 |
DisclosureSEC source: 0001340122-21-000042 · wf-form4_161489881371538.xml · derivative · entry 5 Sajkowski Daniel J · CIK 0001619678 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Units · 41,201 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Phantom Unit is the economic equivalent of a Calumet Specialty Products Partners, L.P. Common Unit. F3 · derivative.exercise_date: 100% of the Phantom Units vest on December 31, 2020. F3 · derivative.expiration_date: 100% of the Phantom Units vest on December 31, 2020. Read SEC document |
| March 03, 2021 Filed Mar 4, 2021 18:00 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | Exercise / conversionPhantom Units · Derivative | 7,882 | $0.00 | $0.00 |
DisclosureSEC source: 0001340122-21-000042 · wf-form4_161489881371538.xml · derivative · entry 4 Sajkowski Daniel J · CIK 0001619678 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Units · 7,882 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Phantom Unit is the economic equivalent of a Calumet Specialty Products Partners, L.P. Common Unit. F2 · derivative.exercise_date: 25% of the Phantom Units vested immediately and the remaining vest ratably over three years on December 31 of each year beginning on December 31, 2018. F2 · derivative.expiration_date: 25% of the Phantom Units vested immediately and the remaining vest ratably over three years on December 31 of each year beginning on December 31, 2018. Read SEC document |
| March 03, 2021 Filed Mar 4, 2021 18:00 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | Exercise / conversionCommon Units | 7,102 | $0.00 | $0.00 |
DisclosureSEC source: 0001340122-21-000042 · wf-form4_161489881371538.xml · nonDerivative · entry 3 Sajkowski Daniel J · CIK 0001619678 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,219 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 03, 2021 Filed Mar 4, 2021 18:00 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | Exercise / conversionCommon Units | 41,201 | $0.00 | $0.00 |
DisclosureSEC source: 0001340122-21-000042 · wf-form4_161489881371538.xml · nonDerivative · entry 2 Sajkowski Daniel J · CIK 0001619678 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,117 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 03, 2021 Filed Mar 4, 2021 18:00 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | Exercise / conversionCommon Units | 7,882 | $0.00 | $0.00 |
DisclosureSEC source: 0001340122-21-000042 · wf-form4_161489881371538.xml · nonDerivative · entry 1 Sajkowski Daniel J · CIK 0001619678 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,916 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 03, 2020 Filed Nov 5, 2020 20:08 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | GrantPhantom Units · Derivative | 27,855 | $0.00 | $0.00 |
DisclosureSEC source: 0001340122-20-000116 · wf-form4_160462491619870.xml · derivative · entry 1 Sajkowski Daniel J · CIK 0001619678 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,855 Underlying: Common Units · 27,855 shares Expires not disclosed F1 · derivative.exercise_price: Each Phantom Unit is the economic equivalent of a Calumet Specialty Products Partners, L.P. Common Unit. F2 · derivative.exercise_date: Phantom Units vest on December 31, 2022. Phantom Units will be settled upon vesting. F2 · derivative.expiration_date: Phantom Units vest on December 31, 2022. Phantom Units will be settled upon vesting. Read SEC document |
| March 24, 2020 Filed Mar 24, 2020 17:55 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | Exercise / conversionPhantom Units · Derivative | 14,204 | $0.00 | $0.00 |
DisclosureSEC source: 0001340122-20-000059 · wf-form4_158508691786324.xml · derivative · entry 2 Sajkowski Daniel J · CIK 0001619678 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,205 Underlying: Common Unit · 14,204 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Phantom Unit is the economic equivalent of a Calumet Specialty Products Partners, L.P. Common Unit. F2 · derivative.exercise_date: 25% of the Phantom Units vested immediately and the remaining vest ratably over three years on December 31 of each year beginning on December 31, 2019. Phantom units will be settled upon vesting. F2 · derivative.expiration_date: 25% of the Phantom Units vested immediately and the remaining vest ratably over three years on December 31 of each year beginning on December 31, 2019. Phantom units will be settled upon vesting. Read SEC document |
| March 24, 2020 Filed Mar 24, 2020 17:55 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | Exercise / conversionCommon Units | 14,204 | $0.00 | $0.00 |
DisclosureSEC source: 0001340122-20-000059 · wf-form4_158508691786324.xml · nonDerivative · entry 1 Sajkowski Daniel J · CIK 0001619678 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,034 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 27, 2020 Filed Mar 2, 2020 21:08 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | GrantPhantom Unit · Derivative | 0 | $3.72 | $0.00 |
DisclosureSEC source: 0001340122-20-000026 · wf-form4_158320129297560.xml · derivative · entry 8 Sajkowski Daniel J · CIK 0001619678 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,736 Underlying: Common Unit · 1,736 shares Expires not disclosed F1 · derivative.exercise_price: Each Phantom Unit is the economic equivalent of a Calumet Specialty Products Partners, L.P. Common Unit. F5 · derivative.exercise_date: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date pursuant to the Deferred Compensation Plan. 25% of the Phantom Units vest on July 1 of each year beginning on July 1, 2021. F5 · derivative.expiration_date: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date pursuant to the Deferred Compensation Plan. 25% of the Phantom Units vest on July 1 of each year beginning on July 1, 2021. Read SEC document |
| February 27, 2020 Filed Mar 2, 2020 21:08 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | GrantPhantom Units · Derivative | 0 | $3.72 | $0.00 |
DisclosureSEC source: 0001340122-20-000026 · wf-form4_158320129297560.xml · derivative · entry 7 Sajkowski Daniel J · CIK 0001619678 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,104 Underlying: Common Units · 5,208 shares Expires not disclosed F1 · derivative.exercise_price: Each Phantom Unit is the economic equivalent of a Calumet Specialty Products Partners, L.P. Common Unit. F4 · derivative.exercise_date: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date. Phantom Units are 100% vested. F4 · derivative.expiration_date: Each Phantom Unit becomes payable either in the form of a Common Unit or the cash value thereof upon the earlier of the date specified by the reporting person or the reporting person's termination date. Phantom Units are 100% vested. Read SEC document |
| February 27, 2020 Filed Mar 2, 2020 21:08 UTC | Calumet Specialty Products Partners, L.P. CLMT · Entity 91042 | Exercise / conversionPhantom Units · Derivative | 7,935 | $0.00 | $0.00 |
DisclosureSEC source: 0001340122-20-000026 · wf-form4_158320129297560.xml · derivative · entry 6 Sajkowski Daniel J · CIK 0001619678 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Units · 7,935 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Phantom Unit is the economic equivalent of a Calumet Specialty Products Partners, L.P. Common Unit. F3 · derivative.exercise_date: 25% of the Phantom Units vest on December 31 of each year beginning on December 31, 2016. F3 · derivative.expiration_date: 25% of the Phantom Units vest on December 31 of each year beginning on December 31, 2016. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.